10 April 2006
Epistatic effects between two genes in the renin-angiotensin system and systolic blood pressure and coronary artery calcification.
Sharon L.R. Kardia, Lawrence F. Bielak, Leslie A. Lange, James M. Cheverud, Eric Boerwinkle, Stephen T. Turner, Patrick F. Sheedy II, Patricia A. PeyserMed Sci Monit 2006; 12(4): CR150-158 :: ID: 448900
Abstract
Background: Coronary artery calcification (CAC) is an important indicatorof future coronary artery disease events. Since elevated blood pressure (BP) is an important predictorof CAC, genetic polymorphisms in the renin-angiotensin system and their interaction may play a role inexplaining CAC quantity variation. Material/Methods: As part of the Epidemiology of Coronary Artery CalcificationStudy, 166 asymptomatic women and 166 asymptomatic men were genotyped for the insertion/deletion polymorphismin the angiotensin-converting enzyme (ACE) gene and the -6 promoter polymorphism of the angiotensinogen(AGT) gene. We used a novel method to detect gene-gene interaction and compared it to the standard two-wayanalysis of variance (ANOVA) method. Results: Based on a two-way ANOVA model, there was no evidence forepistasis for either systolic BP or CAC in either men or women. However, using a novel method, we foundevidence of significant gene-gene interaction in systolic BP in men and gene-gene interaction in bothsystolic BP levels and CAC quantity in women. Conclusions: Our study demonstrates that new methods ofassessing epistasis maybe important in understanding the complex genetics of systolic blood pressureas well as subclinical coronary atherosclerosis.
Keywords: Epistasis, Genetic, Renin-Angiotensin System - genetics, Promoter Regions, Genetic, Polymorphism, Genetic, Peptidyl-Dipeptidase A - genetics, Genotype, Aged, 80 and over, DNA - genetics, Coronary Vessels - pathology, Coronary Artery Disease - genetics, Calcinosis - genetics, Blood Pressure - genetics, Base Sequence, Angiotensinogen - genetics
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952